Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Neuroepidemiology. 2012 Oct 24;40(2):73–84. doi: 10.1159/000342761

Figure 3.

Figure 3

Ante-mortem brain MRI scan demonstrating cerebrovascular disease in vivo*

*T1-weighted MP-RAGE (A) and T2-weighted FLAIR (B) images of two slices of a MAP participant, demonstrating examples of infarcts (white arrow) and white matter hyperintensities (gray arrows).